Abstract
When screening for cancer in older adults, it is important to consider the risks of screening, how long it takes to benefit from screening, and the patient's comorbidities and life expectancy. Delivering high-value care requires the consideration of evidence-based screening guidelines and careful selection of patients. This article considers the impact of cancer. It explores perspectives on the costs of common cancer screening tests, illustrates how using life expectancy can help clinicians determine who will benefit most from screening, and provides tools to help clinicians discuss with their older patients when it may be appropriate to stop screening for cancer.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1101-1110 |
| Number of pages | 10 |
| Journal | Medical Clinics of North America |
| Volume | 100 |
| Issue number | 5 |
| DOIs | |
| State | Published - Jan 1 2016 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Medicine(all)
Cite this
}
Cancer Screening in Older Adults. / Snyder, Ashley; Magnuson, Allison; Westcott, Amy.
In: Medical Clinics of North America, Vol. 100, No. 5, 01.01.2016, p. 1101-1110.Research output: Contribution to journal › Review article
TY - JOUR
T1 - Cancer Screening in Older Adults
AU - Snyder, Ashley
AU - Magnuson, Allison
AU - Westcott, Amy
PY - 2016/1/1
Y1 - 2016/1/1
N2 - When screening for cancer in older adults, it is important to consider the risks of screening, how long it takes to benefit from screening, and the patient's comorbidities and life expectancy. Delivering high-value care requires the consideration of evidence-based screening guidelines and careful selection of patients. This article considers the impact of cancer. It explores perspectives on the costs of common cancer screening tests, illustrates how using life expectancy can help clinicians determine who will benefit most from screening, and provides tools to help clinicians discuss with their older patients when it may be appropriate to stop screening for cancer.
AB - When screening for cancer in older adults, it is important to consider the risks of screening, how long it takes to benefit from screening, and the patient's comorbidities and life expectancy. Delivering high-value care requires the consideration of evidence-based screening guidelines and careful selection of patients. This article considers the impact of cancer. It explores perspectives on the costs of common cancer screening tests, illustrates how using life expectancy can help clinicians determine who will benefit most from screening, and provides tools to help clinicians discuss with their older patients when it may be appropriate to stop screening for cancer.
UR - http://www.scopus.com/inward/record.url?scp=84998785488&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84998785488&partnerID=8YFLogxK
U2 - 10.1016/j.mcna.2016.04.016
DO - 10.1016/j.mcna.2016.04.016
M3 - Review article
C2 - 27542429
AN - SCOPUS:84998785488
VL - 100
SP - 1101
EP - 1110
JO - Medical Clinics of North America
JF - Medical Clinics of North America
SN - 0025-7125
IS - 5
ER -